Aligos Therapeutics to Announce 4th Quarter 2024 Financial Results on March 10, 2025

Company Overview - Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing best-in-class therapies for liver and viral diseases [2] - The company aims to improve patient outcomes through its science-driven approach and deep R&D expertise [2] Financial Announcement - Aligos Therapeutics will report its fourth quarter 2024 financial results on March 10, 2025, before the U.S. financial markets open [1] Pipeline and Therapeutic Focus - The company is advancing a pipeline of therapeutics targeting high unmet medical needs, including chronic hepatitis B virus infection, metabolic dysfunction-associated steatohepatitis (MASH), and coronaviruses [2]